DANA POINT, Calif., Oct. 29 /PRNewswire-USNewswire/ -- Howard A. McLure, President of Caremark Pharmacy Services, a division of CVS Caremark was elected Chairman of the Pharmaceutical Care Management Association's (PCMA) Board of Directors, the association announced today. In addition to becoming the new Board Chairman, Mr. McLure was also a keynote speaker at PCMA's Annual Meeting, a two-day event which features health care leaders discussing the latest industry trends and information.
"As the new Chairman of the Board for PCMA, we are excited to have Howard McLure's leadership on the important pharmacy issues we face as an industry both currently and looking down the road," said PCMA President and CEO Mark Merritt. "Howard will continue the progress we've achieved during the past year under the stewardship of outgoing PCMA Board Chairman, George Paz, Chairman, President and CEO of Express Scripts, Inc."
In his address at PCMA's Annual Meeting, Mr. McLure called on the association to continue working collaboratively to demonstrate industry value.
"Whether you are here today representing a PBM company, a health plan, an employer group, a drug manufacturer, or some other constituency, we all are linked by one common denominator: the desire for improved outcomes-both financial and clinical-for our customers, their beneficiaries and other stakeholders, where pharmacy services are concerned," said Mr. McLure. "I view this association as an arbiter of sound and responsible policies that move us all closer to achieving that shared goal."
Caremark Pharmacy Services is the pharmacy benefit management, mail
order and specialty pharmacy division of CVS Caremark, the largest provider
of prescriptions and related healthcare services in the nation. Prior to
his current role, Mr. McLure was Senior Executive Vice President and Chief
Operating Officer of Caremark Rx, Inc. from June 2005 until the closing of
the CVS Caremark merger, when he became
'/>"/>
| SOURCE Pharmaceutical Care Management Association Copyright©2007 PR Newswire. All rights reserved |